News Conference News ESC 2024 ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions Michael O'Riordan September 17, 2024
News Conference News ACC 2024 IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM Caitlin E. Cox April 15, 2024
News Conference News AHA 2023 Coincidental Nonischemic Cardiomyopathy Impacts Prognosis in CAD Todd Neale November 09, 2023
News Conference News AHA 2022 Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock Caitlin E. Cox November 06, 2022
News Conference News ESC 2022 PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2 Michael O'Riordan August 27, 2022
News Conference News THT 2022 LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety Caitlin E. Cox February 02, 2022
News Conference News ACC 2021 ‘Enormous’ QoL Improvements With Mavacamten in HCM Shelley Wood May 15, 2021
News Conference News ESC 2020 Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF Michael O'Riordan August 31, 2020
News Conference News AHA 2019 AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials Shelley Wood November 11, 2019
News Conference News ESC Heart Failure 2019 Steep Rise in PCI for Ischemic Heart Failure Seen in Sweden, but Survival Favors CABG Shelley Wood May 28, 2019
News Conference News ACC 2019 ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend Shelley Wood March 11, 2019
News Conference News ESC 2018 New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All Michael O'Riordan August 29, 2018
News Conference News Cell Therapy 2012 Novel Strategies Advance Cell Therapy for Cardiomyopathy February 05, 2012
News Conference News STICH: CABG Does Not Extend Survival Over Medical Therapy in Heart Failure Patients Caitlin E. Cox April 04, 2011